FP7
WEB-RADR
Recognising Adverse Drug Reactions
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 40 months
- Total cost
- EUR 5,940,396
- EU contribution
- EUR 2,270,000
- Participants
- 18 from 10 countries
- Topic
- FP7_IMI-JU-09-2013-01
- Grant agreement
- 115632
Coordinated by Novartis Pharma AG (CHSwitzerland).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Novartis Pharma AG | CHSwitzerland | Coordinator | Not stated | PIC (1.00) |
| Amgen | BEBelgium | Participant | Not stated | PIC (1.00) |
| Janssen Pharmaceutica NV | BEBelgium | Participant | Not stated | PIC (1.00) |
| Ucb Biopharma | BEBelgium | Participant | Not stated | PIC (1.00) |
| Bayer Pharma AG | DEGermany | Participant | Not stated | PIC (1.00) |
| Eurordis - Rare Diseases Europe | FRFrance | Participant | EUR 80,475 | PIC (1.00) |
| Sanofi-Aventis Recherche & Developpement | FRFrance | Participant | Not stated | PIC (1.00) |
| Department of Health | GBUnited Kingdom | Participant | EUR 330,342 | known name (0.95) |
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| The University of Liverpool | GBUnited Kingdom | Participant | EUR 276,548 | PIC (1.00) |
| Agencija za Lijekove i Medicinske Proizvode | HRCroatia | Participant | EUR 49,374 | known name (0.95) |
| Epidemico Limited | IEIreland | Participant | EUR 519,335 | PIC (1.00) |
| Academisch Ziekenhuis Groningen | NLNetherlands | Participant | EUR 100,526 | PIC (1.00) |
| Stichting Lareb | NLNetherlands | Participant | EUR 138,249 | PIC (1.00) |
| The European Medicines Agency | NLNetherlands | Participant | EUR 246,878 | PIC (1.00) |
| Astrazeneca AB | SESweden | Participant | Not stated | PIC (1.00) |
| Stiftelsen WHO Collaborating Centre for International Drug Monitoring | SESweden | Participant | EUR 340,773 | PIC (1.00) |
| Srdc Yazilim Arastirma Ve Gelistirme Ve Danismanlik Ticaret Anonim Sirketi | TRTürkiye | Participant | EUR 75,000 | PIC (1.00) |
Changes of the consortium
First seen on with 18 participants from 10 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.